Literature DB >> 29998165

A Complex Case of Cholestasis in a Patient with ABCB4 and ABCB11 Mutations.

Mariana Ferreira Cardoso1, Joana Carvalho E Branco1, Vera Anapaz1, Catarina Graça Rodrigues1, Rita Carvalho1, David Horta1, Alexandra Martins1, Jorge Reis1.   

Abstract

The low-phospholipid-associated cholelithiasis (LPAC) syndrome is a form of symptomatic cholelithiasis occurring in young adults, characterized by recurrence of symptoms after cholecystectomy and presence of hepatolithiasis. The case refers to a healthy 39-year-old Caucasian male who presented with abdominal pain and jaundice. His blood tests showed conjugated hyperbilirubinemia and elevated liver enzymes (total bilirubin 6.65 mg/dL, γ-glutamyltransferase 699 IU/L) and abdominal computed tomography revealed dilation of common bile duct and left intrahepatic ducts. Magnetic resonance cholangiopancreatography identified choledocholithiasis, retrieved by endoscopic retrograde cholangiopancreatography, after which there was a worsening of jaundice (total bilirubin 23 mg/dL), which persisted for several weeks, possibly due to ciprofloxacin toxicity. After an extensive workup including liver biopsy, the identification of two foci of hepatolithiasis on reevaluation abdominal ultrasound raised the hypothesis of LPAC syndrome and the patient was started on ursodeoxycholic acid, with remarkable improvement. Genetic testing identified the mutation c.1954A>G (p.Arg652Gly) in ABCB4 gene (homozygous) and c.1331T>C (p.Val444Ala) in ABCB11 gene (heterozygous). In conclusion, we describe the unique case of an adult male with choledocholithiasis, hepatolithiasis, and persistent conjugated hyperbilirubinemia after retrieval of stones, fulfilling the criteria for LPAC syndrome and with possible superimposed drug-induced liver injury, in whom ABCB4 and ABCB11 mutations were found, both of which had not been previously described in association with LPAC.

Entities:  

Keywords:  BSEP; Drug-induced liver injury; Low-phospholipid-associated cholelithiasis; MDR3

Year:  2017        PMID: 29998165      PMCID: PMC6029212          DOI: 10.1159/000484612

Source DB:  PubMed          Journal:  GE Port J Gastroenterol        ISSN: 2387-1954


  25 in total

1.  A Rare BSEP Mutation Associated with a Mild Form of Progressive Familial Intrahepatic Cholestasis Type 2.

Authors:  Orith Waisbourd-Zinman; Lea F Surrey; Anna E Schwartz; Pierre A Russo; Jessica Wen
Journal:  Ann Hepatol       Date:  2017 May - Jun       Impact factor: 2.400

2.  The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood.

Authors:  E Jacquemin; J M De Vree; D Cresteil; E M Sokal; E Sturm; M Dumont; G L Scheffer; M Paul; M Burdelski; P J Bosma; O Bernard; M Hadchouel; R P Elferink
Journal:  Gastroenterology       Date:  2001-05       Impact factor: 22.682

Review 3.  The spectrum of liver diseases related to ABCB4 gene mutations: pathophysiology and clinical aspects.

Authors:  Anne Davit-Spraul; Emmanuel Gonzales; Christiane Baussan; Emmanuel Jacquemin
Journal:  Semin Liver Dis       Date:  2010-04-26       Impact factor: 6.115

4.  MDR3 P-glycoprotein, a phosphatidylcholine translocase, transports several cytotoxic drugs and directly interacts with drugs as judged by interference with nucleotide trapping.

Authors:  A J Smith; A van Helvoort; G van Meer; K Szabo; E Welker; G Szakacs; A Varadi; B Sarkadi; P Borst
Journal:  J Biol Chem       Date:  2000-08-04       Impact factor: 5.157

5.  Mutations and polymorphisms in the bile salt export pump and the multidrug resistance protein 3 associated with drug-induced liver injury.

Authors:  Carmen Lang; Yvonne Meier; Bruno Stieger; Ulrich Beuers; Thomas Lang; Reinhold Kerb; Gerd A Kullak-Ublick; Peter J Meier; Christiane Pauli-Magnus
Journal:  Pharmacogenet Genomics       Date:  2007-01       Impact factor: 2.089

6.  Genotype-phenotype relationships in the low-phospholipid-associated cholelithiasis syndrome: a study of 156 consecutive patients.

Authors:  Raoul Poupon; Olivier Rosmorduc; Pierre Yves Boëlle; Yves Chrétien; Christophe Corpechot; Olivier Chazouillères; Chantal Housset; Véronique Barbu
Journal:  Hepatology       Date:  2013-07-29       Impact factor: 17.425

7.  ABCB4 heterozygous gene mutations associated with fibrosing cholestatic liver disease in adults.

Authors:  Marianne Ziol; Véronique Barbu; Olivier Rosmorduc; Annonciade Frassati-Biaggi; Nathalie Barget; Brigitte Hermelin; Georges L Scheffer; Selma Bennouna; Jean-Claude Trinchet; Michel Beaugrand; Nathalie Ganne-Carrié
Journal:  Gastroenterology       Date:  2008-03-26       Impact factor: 22.682

8.  Phosphatidylcholine translocase: a physiological role for the mdr2 gene.

Authors:  S Ruetz; P Gros
Journal:  Cell       Date:  1994-07-01       Impact factor: 41.582

Review 9.  The bile salt export pump (BSEP) in health and disease.

Authors:  Ralf Kubitz; Carola Dröge; Jan Stindt; Katrin Weissenberger; Dieter Häussinger
Journal:  Clin Res Hepatol Gastroenterol       Date:  2012-07-12       Impact factor: 2.947

10.  Benign recurrent intrahepatic cholestasis. A report of 26 cases.

Authors:  R Brenard; A P Geubel; J P Benhamou
Journal:  J Clin Gastroenterol       Date:  1989-10       Impact factor: 3.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.